A Study Comparing the Pharmacokinetic Similarity of MB02-SP, MB02-DM and US Licensed-Avastin®.
Clinical trial NCT04408989 · COMPLETED
Trial details
- NCT number
- NCT04408989
- Sponsor
- mAbxience Research S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2021-08-20
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.